Scientists and academics in Arizona and Maryland are looking for 76 veterans suffering from PTSD to fire up just under 2 grams of weed daily.
Igniting a new study designed to investigate the medicinal value of marijuana and its magical cannabinoids in the treatment of posttraumatic stress disorder (PTSD), the research will be performed at Baltimore’s Johns Hopkins University and Dr. Sisley’s Scottsdale Research Institute in Phoenix, Arizona.
According to a post in yesterday’s MilitaryTimes.com, “A total of 76 combat veterans will be tested over 12 weeks, but only about four subjects will begin each month across both sites, so the study itself is expected to take two years to complete.”
Hoping to clear the smoke of ambiguity with just the right candidates, Dr. Sisley noted, the “ideal” vet would be considered generally healthy and already be rated on their disability from the VA for their combat-related posttraumatic stress disorder.
Following an initial screening and appraisal of the candidate’s condition, anticipated to take approximately two weeks, participating vets will be arbitrarily given four types of cannabis with specific cannabinoid profiles:
Some of those veterans that successfully pass the initial screening process will be allocated 1.8 grams of cannabinoid-rich pot on a weekly basis. Prohibiting the use of electronic vaporizers, vets will be encouraged to use a pipe and adjust their daily intake, based on their perceived symptoms – making sure not to exceed their daily allocation.
For the $2.2 million PTSD research, participating vets will be provided an iPad for documenting their consumption and the resulting experience. Provided this research nets the anticipated results, the Multidisciplinary Association for Psychedelic Studies, otherwise known as MAPS, will lobby for the use of “smoked botanical marijuana” as a federally acknowledged prescription for the treatment of PTSD.
Those vets living near Phoenix and looking to participate in Dr. Sisley’s study should contact email@example.com.